SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000884731-16-000085
Filing Date
2016-07-14
Accepted
2016-07-14 16:23:56
Documents
3
Period of Report
2016-07-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_146852779656288.html 4  
1 FORM 4 wf-form4_146852779656288.xml 4 7051
2 PARIS POA paris_001.jpg GRAPHIC 216319
3 PARIS POA paris_.htm EX-24 579
  Complete submission text file 0000884731-16-000085.txt   307090
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Issuer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Panayiotopoulos Paris (Reporting) CIK: 0001662996 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36172 | Film No.: 161767617